Corresponding Author: Gary W. Falk, MD, MS, Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Perelman Center for Advanced Medicine, 3400 Civic Center Blvd, 7th Floor, South Pavilion, Philadelphia, PA 19104 (gary.falk@pennmedicine.upenn.edu).
Accepted for Publication: August 17, 2021.
Author Contributions: Drs Muir and Falk had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Both authors.
Acquisition, analysis, or interpretation of data: Both authors.
Drafting of the manuscript: Both authors.
Critical revision of the manuscript for important intellectual content: Both authors.
Administrative, technical, or material support: Both authors.
Conflict of Interest Disclosures: Dr Muir reported receiving research funding from Allakos. Dr Falk reported receiving research funding from Allakos, Arena, Adare/Ellodi, Bristol Myers Squibb, Celgene, Lucid, Regeneron, and Shire/Takeda and is a consultant for Allakos, Adare/Ellodi, Bristol Myers Squibb/Celgene, Lucid, Sanofi, and Shire/Takeda.
Funding/Support: This work was supported in part by the National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Center for Molecular Studies in Digestive and Liver Disease (P30DK050306) and by the Consortium for Eosinophilic Gastrointestinal Disease Research (CEGIR) (U54 AI117804), which is part of the Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), and is funded through collaboration between the National Institute of Allergy and Infectious Diseases, NIDDK, and NCATS. CEGIR is also supported by patient advocacy groups including the American Partnership for Eosinophilic Disorders, Campaign Urging Research for Eosinophilic Diseases, and Eosinophilic Family Coalition. As a member of the RDCRN, CEGIR is also supported by its data management and coordinating center (U2CTR002818). Dr Muir is funded by NIH grants R01 DK124266-01 and R21TR00303902.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.